CD81 and neoplasm: CD81-positive sEVs mediate viral immune evasion and promote tumor progression in HCV-associated HCC; HCV viral particles exploit CD81-positive sEVs for transmission, and this sEVs subpopulation is significantly enriched in HCV-positive HCC patients, suggesting its potential as a therapeutic target (59).